Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Cancer Discovery|June 17, 2017
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS LymphomaChristian Grommes, Alessandro Pastore, Nicolaos Palaskas, et al.
Research Square|November 19, 2025
Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective StudyMatthew Hamby, Brian Egleston, Zachary Frosch, et al.
Blood Cancer Discovery|May 8, 2025
DNA methylation epitypes of Burkitt lymphoma with distinct molecular and clinical featuresNicole Thomas, Carlos A García-Prieto, Kostiantyn Dreval, et al.
The Lancet. Haematology|November 26, 2021
Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trialJacob D Soumerai, Anthony R Mato, Ahmet Dogan, et al.
Blood Cancer Journal|March 24, 2026
Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective studyMatthew Hamby, Brian L Egleston, Zachary A K Frosch, et al.
Blood|January 9, 2019
Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphomaBruno M Grande, Daniela S Gerhard, Aixiang Jiang, et al.
Blood Advances|June 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKsJacob D Soumerai, Meghan C Thompson, Ahmet Dogan, et al.
Blood|October 6, 2022
Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphomaNicole Thomas, Kostiantyn Dreval, Daniela S Gerhard, et al.
Pageof 14